27 March 2024
JAMES HALSTEAD PLC
INTERIM RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2023
Strong H1 profitability and record interim dividend; solid margins and profit performance continue into H2
Key Figures
James Halstead plc, the AIM listed manufacturer and international distributor of floor coverings, announces its results for the six months ended 31 December 2023:
Financial highlights
· Revenue at £136.5 million (2022: £149.6 million) |
· Operating profit at £26.2 million (2022: £23.1 million) |
· Pre-tax profit at £27.4 million (2022: £23.2 million) |
· Basic earnings per ordinary share 4.8p (2022: 4.3p) |
· Interim dividend declared of 2.50p (2022: 2.25p) |
· Cash of £62.4 million (2022: £44.3 million) |
The Chief Executive, Mr. Mark Halstead, commented:
"Against difficult markets we have raised profits and are confidently growing our export of UK manufactured goods across the globe. Once again, we have declared a record interim dividend to shareholders to reward their continued investment".
Enquiries:
James Halstead: |
|
Mark Halstead, Chief Executive | Telephone: 0161 767 2500 |
Gordon Oliver, Finance Director |
|
Hudson Sandler: |
|
Nick Lyon | Telephone: 020 7796 4133 |
Nick Moore |
|
Panmure Gordon (NOMAD & Joint Broker): |
|
Dominic Morley | Telephone: 020 7886 2500 |
WH Ireland (Joint Broker): |
|
Ben Thorne | Telephone: 0207 220 1666 |
CHAIRMAN'S STATEMENT
Trading for the six months ended 31 December 2023
Sales revenue of £136.5 million (2022: £149.6 million) was 8.8% lower than the prior year, primarily due to recessionary pressures in several major markets and delays in the rebuilding of our UK manufactured flooring export markets.
Profit before tax of £27.4 million (2022: £23.2 million) is 18% ahead of the comparative period, driven partly by higher rates of interest received on cash deposits and more importantly by increased operating profit which was 13.6% ahead of the prior year.
The turnover shortfalls relative to the comparative period were: Europe -15%, Australasia -13% and the UK -5%. The rest of the world showed 4% growth. The key growth areas were South America (+36%), the Middle East (+26%) and the Mediterranean (+22%).
Lack of availability of raw materials, lack of timely shipping and labour restrictions hampered export of manufactured goods significantly in calendar year 2021 and 2022. However, it is pleasing to see that the various bottlenecks that affected our exports in prior years are now largely cleared and we have been focused on restoring the project pipeline in order to facilitate sales growth in certain markets.
Margins have improved as manufacturing output increased significantly compared to the comparative period, up 62%. Gross margins in all major markets improved as productivity improvements in manufacturing output were realised and with a product shift to higher added value ranges. Exceptions to this general improvement were New Zealand, Malaysia and India where we were not able to fully recoup the added cost of transport of goods to these markets in late 2022 and early 2023 through price increases. However, the transportation cost fell steadily from March 2023 onwards to near normal levels by December 2023.
Our UK businesses (Polyflor and Riverside) fared well with manufacturing efficiencies through increased output more than offsetting the slightly lower sales in the UK. Exports from the UK to our own subsidiaries were much higher than the comparatives (principally Australia, New Zealand and Canada) and will translate into external sales as the stock arrives locally.
The principal area of sales shortfall against the prior year was in the product group of luxury vinyl tiles which was unsurprising given these ranges cross into the domestic consumer market. In the UK our sales model is to supply product in breadth and depth via the distribution trade whilst maintaining sales communication with the end customer and the flooring contractors. Our distribution customers often also supply domestic flooring of which the largest component is historically carpet, where consumer confidence and spending has suffered in recent years. Notwithstanding these difficulties, there is growth in the distribution trade and we continue to focus on this route to our end customers. The polyvinyl solution for flooring continues to increase its share of the market. The durability, cleanability and recyclability of vinyl combined with the cost, design choice and availability are key to the success of our flooring ranges.
Our German and Central European businesses are operating in an economic climate characterised by great uncertainty. Despite the difficulty in achieving sales, the underlying profit mix is favourable and profit has held up very well. The retail-shop refurbishment market, which has been a core strength, has suffered as many retail chains are facing challenging consumer demand and consequently renovation and new store opening plans are in many cases on hold. Notwithstanding this, we have delivered several key projects such as the "New Yorker", "Tom Tailor" and "Smyths Toy" store chains across the DACH region alongside projects such as the Papenburg Meyer shipyard, Marseille Airport duty free area and the new Lidl HQ in France. Despite softening demand in the European market, price increases were implemented in early 2023 and the product mix generally improved with higher value commercial ranges generally selling better than the "semi-commercial" / heavy domestic products. Objectflor were the recipients of the German flooring contractors association' (Netzwerk Boden) flooring project of the year for POHA House in Aachen, a listed building converted to living / work accommodation.
Canada faced a difficult trading climate with delayed construction projects and constrained budgets due to inflationary pressures. Nevertheless, like-for-like sales, in local currency, increased by 9%. Key projects such as the renovation of Rexell Pharmacy's stores and the Terra Hill Medical Centre are just two examples of installations in this market. As with other regions, margins improved and the net profit in Canada was over 50% higher (a record level).
Sales in the APAC region were mixed with New Zealand showing a modest growth (4%) in same currency, Malaysia was on a par with the comparative, Australia saw a 9% reduction and China down around 10%. Market conditions in New Zealand were difficult with the housing market facing an almost 40% decline in new builds. Despite this, our business was successful in driving sales into social housing initiatives. Range consolidation to ensure greater stocks in narrower colour/design options is helping to focus the commercial sales team on projects. Australia also faced challenges, most notably in the effects of interest rate rises on consumer confidence and a much decreased level of retail footfall, the latter having an effect on the rate of retail store refurbishment and expansion. In addition, there were delays / deferment of government social housing initiatives. Stock shortages in the early part of the period were also an issue due to the shipping delays of the prior year. Nevertheless Australia and New Zealand continued to supply projects such as the Footscray Hospital in Victoria and the Takanaki Base Hospital in New Plymouth.
We continue to make progress in Malaysia and South Asia. Fresh stock from Polyflor in the UK is starting to bolster margins and orders have been secured from projects not only in Malaysia but also Singapore, Indonesia and Vietnam.
North Asia, notably China, Hong Kong and South Korea continue to fall short of pre pandemic levels of sales as these markets suffered the worst of the supply chain issues from UK manufacturing sites throughout 2021-2022. Our North Asian team are rebuilding customer confidence with several key projects targeted.
Projects such as Nhan Le Kindergarten Hospital and the National Childrens Hospital (both in Vietnam), Sunway Hospital in Selangor, Malaysia and Skol4kds Childcare Centres in Singapore all continue our long association with the region. This can only deepen as The Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) free trade agreement progresses to full ratification during 2024. UK manufactured products have always been welcomed in these markets and any trade agreement can only accentuate ongoing trade.
In the rest of the world, we delivered a myriad of projects from the Vox Cinemas in Kuwait to Coomeva Medicina Prepagada in Colombia.
Earnings per share and dividend
Since the start of the financial year we have distributed £24.0 million in dividends and paid corporation taxes of £8.2 million. In addition, capital expenditure over the same period was £2.1 million. The cash inflow from operations at £33.6 million significantly exceeds last year (2022: £22.7 million). Our cash, which stands at £62.4 million as of 31 December 2023 compared with £44.3 million at 31 December 2022, continues to be a key strength.
Having regard to our cash and profitability, we have decided to declare an interim dividend of 2.50p per share (2022: 2.25p), an increase of 11.1%. This dividend will be payable on 14 June 2024 to those shareholders on the register as at 17 May 2024.
Current trading and outlook
The breadth and depth of our projects across the globe continue to drive a diverse sales mix, from the renovation of the Novopecherska Primary school, in Kyiv, Hospital El Salvador, the major hospital in Chile, the UN Offices in Nairobi, Kenya to the Unimed Hospitals in Brazil. The recent disruption to shipping in the Red Sea has, to a degree, lengthened delivery times and increased costs which is complicating exports to our APAC markets and frustrating (to a small degree) the return to pre-pandemic norms for freight in respect of availability and cost.
The shortfall in sales against the comparative in the first six months to 31 December 2023 was largely attributed to lower consumer confidence in major markets and delays in rebuilding supply to export markets. In January and February, sales of manufactured goods are in line with last year's record comparatives and overall, UK activity is showing improved confidence against the last six months. In Europe there is a similar zeitgeist of positive sentiment. Similarly, export markets continue to show positive prospects for growth as our sales teams continue quoting on projects, with our highly regarded ranges of flooring, for timely delivery, around the world.
Margins remain solid and overheads are contained within inflationary parameters. Consequently, the improved first half profitability continues into the early months of the second half of the year. I, and the board, remain confident of making further progress.
Anthony Wild
Chairman
27 March 2024
Consolidated Income Statement
for the half-year ended 31 December 2023
|
Half-year ended 31.12.23 £'000 |
Half-year ended 31.12.22 £'000 |
Year ended 30.06.23 £'000 |
|
| | |
Revenue | 136,451 | 149,638 | 303,562 |
|
| | |
Operating profit | 26,213 | 23,085 | 51,611 |
Finance income | 1,339 | 230 | 748 |
Finance cost | (156) | (95) | (260) |
|
| | |
Profit before income tax | 27,396 | 23,220 | 52,099 |
|
| | |
Income tax expense | (7,317) | (5,176) | (9,695) |
|
| | |
Profit for the period | 20,079 | 18,044 | 42,404 |
|
| | |
|
| | |
Earnings per ordinary share of 5p: |
| | |
- basic | 4.8p | 4.3p | 10.2p |
- diluted | 4.8p | 4.3p | 10.2p |
|
| | |
All amounts relate to continuing operations.
Details of dividends paid and declared/proposed are given in note 4.
Consolidated Statement of Comprehensive Income
for the half-year ended 31 December 2023
|
| | |
|
|
| |
| Half-year ended 31.12.23 £'000
| Half-year ended 31.12.22 £'000
| Year ended 30.06.23 £'000
|
Profit for the period | 20,079 | 18,044 | 42,404 |
Other comprehensive income net of tax: |
| | |
Remeasurement of the net defined benefit liability | (959) | (4,948) | (7,237) |
Foreign currency translation differences | 439 | 63 | (1,818) |
Fair value movements on hedging instruments | (1,086) | (1,297) | (135) |
|
| | |
Other comprehensive income for the period net of tax |
(1,606) |
(6,182) | (9,190) |
|
| | |
Total comprehensive income for the period | 18,473 | 11,862 | 33,214 |
|
| | |
Attributable to equity holders of the parent | 18,473 | 11,862 | 33,214 |
Consolidated Balance Sheet
as at 31 December 2023
| Half-year ended 31.12.23 £'000 | Half-year ended 31.12.22 £'000 | Year ended 30.06.23 £'000 |
Non-current assets |
| | |
Intangible assets | 3,232 | 3,232 | 3,232 |
Property, plant and equipment | 36,116 | 36,265 | 35,887 |
Right of use assets | 6,804 | 8,914 | 7,164 |
Retirement benefit obligations | - | 499 | - |
Deferred tax | 118 | 236 | 114 |
| 46,270 | 49,146 | 46,397 |
Current assets |
| | |
Inventories | 83,118 | 93,863 | 87,440 |
Trade and other receivables | 35,623 | 39,053 | 46,979 |
Derivative financial instruments | 60 | 286 | 773 |
Current tax Cash and cash equivalents | 1,012 62,420 | - 44,325 | 699 63,222 |
| 182,233 | 177,527 | 199,113 |
|
| | |
Total assets | 228,503 | 226,673 | 245,510 |
|
| |
|
Current liabilities |
| |
|
Trade and other payables | 49,173 | 49,788 | 60,738 |
Derivative financial instruments | 735 | 1,406 | 213 |
Current tax | - | 2,198 | 422 |
Lease liabilities | 2,586 | 2,906 | 2,696 |
| 52,494 | 56,298 | 64,069 |
|
| | |
Non-current liabilities |
| | |
Retirement benefit obligations | 2,240 | - | 1,460 |
Other payables | 408 | 432 | 400 |
Lease liabilities | 4,359 | 6,093 | 4,582 |
Preference shares | 200 | 200 | 200 |
Deferred tax
| 62 | 1,425 | 585 |
| 7,269 | 8,150 | 7,227 |
|
| | |
Total liabilities | 59,763 | 64,448 | 71,296 |
|
| | |
Net assets | 168,740 | 162,225 | 174,214 |
|
| | |
Equity |
| | |
Equity share capital | 20,838 | 20,838 | 20,838 |
Equity share capital (B shares) | 160 | 160 | 160 |
| 20,998 | 20,998 | 20,998 |
Share premium account | 13 | 13 | 13 |
Currency translation reserve | 4,533 | 5,975 | 4,094 |
Hedging reserve | (280) | (356) | 806 |
Retained earnings | 143,476 | 135,595 | 148,303 |
Total equity attributable to shareholders of the parent | 168,740 | 162,225 | 174,214 |
|
| | |
Consolidated Cash Flow Statement
for the half-year ended 31 December 2023
| Half-year ended 31.12.23 £'000 | Half-year ended 31.12.22 £'000 | Year ended 30.06.23 £'000 |
|
| | |
Profit for the period | 20,079 | 18,044 | 42,404 |
Income tax expense | 7,317 | 5,176 | 9,695 |
Profit before income tax | 27,396 | 23,220 | 52,099 |
Finance cost | 156 | 95 | 260 |
Finance income | (1,339) | (230) | (748) |
Operating profit | 26,213 | 23,085 | 51,611 |
Depreciation of property, plant & equipment | 1,859 | 1,712 | 3,461 |
Depreciation of right of use assets | 1,496 | 1,578 | 3,060 |
Profit on sale of property, plant and equipment | (20) | (26) | (84) |
Defined benefit pension scheme service cost | - | 154 | 178 |
Defined benefit pension scheme employer contributions paid |
(531) |
(975) |
(1,942) |
Change in fair value of financial instruments | - | (564) | (776) |
Share based payments | 16 | 12 | 26 |
Decrease in inventories | 4,832 | 19,008 | 22,966 |
Decrease in trade and other receivables | 11,669 | 11,975 | 3,031 |
(Decrease) in trade and other payables | (11,961) | (33,225) | (20,365) |
Cash inflow from operations | 33,573 | 22,734 | 61,166 |
Taxation paid | (8,234) | (4,957) | (11,900) |
Cash inflow from operating activities | 25,339 | 17,777 | 49,266 |
|
| | |
Interest received | 1,339 | 99 | 467 |
Purchase of property, plant and equipment | (2,058) | (1,143) | (2,854) |
Proceeds from disposal of property, plant and equipment | 38 | 47 | 134 |
Cash outflow from investing activities | (681) | (997) | (2,253) |
|
| | |
|
| | |
Interest paid | (10) | (7) | (36) |
Lease interest paid | (114) | (88) | (224) |
Lease capital paid | (1,474) | (1,573) | (3,015) |
Equity dividends paid | (23,963) | (22,921) | (32,298) |
Shares issued | - | 14 | 14 |
Cash outflow from financing activities | (25,561) | (24,575) | (35,559) |
|
| | |
|
| | |
Net (decrease) / increase in cash and cash equivalents | (903) | (7,795) | 11,454 |
|
| | |
Effect of exchange differences on cash and cash equivalents |
101 |
(24) |
(376) |
Cash and cash equivalents at start of period | 63,222 | 52,144 | 52,144 |
|
| | |
Cash and cash equivalents at end of period | 62,420 | 44,325
| 63,222 |
Notes to the Interim Results
for the half-year ended 31 December 2023
1. | Basis of preparation
| |||
| The interim financial statements are unaudited and do not constitute statutory accounts as defined within the Companies Act 2006.
The principal accounting policies applied in the preparation of the consolidated interim statements are those set out in the annual report and accounts for the year ended 30 June 2023.
The figures for the year ended 30 June 2023 are an abridged statement of the group audited accounts for that year. The financial statements for the year ended 30 June 2023 were audited and have been delivered to the Registrar of Companies.
As is permitted by the AIM rules, the directors have not adopted the requirements of IAS 34 'Interim Financial Reporting' in preparing the interim financial statements. Accordingly the interim financial statements are not in full compliance with IFRS.
| |||
| | |||
2. | Taxation
| |||
| Income tax has been provided at the rate of 26.7% (2022: 22.3%).
| |||
3. | Earnings per share | | | |
| |
Half-year ended 31.12.23 £'000 |
Half-year ended 31.12.22 £'000 |
Year ended 30.06.23 £'000 |
| | | | |
| Profit for the period | 20,079 | 18,044 | 42,404 |
| |
| | |
| Weighted average number of shares in issue | 416,754,052 | 416,751,498 | 416,752,764 |
| Dilution effect of outstanding share options | 33,687 | 23,830 | 21,390 |
| Diluted weighted average number shares | 416,787,739 | 416,775,328 | 416,774,154 |
| |
| | |
| Basic earnings per 5p ordinary share | 4.8p | 4.3p | 10.2p |
| Diluted earnings per 5p ordinary share | 4.8p | 4.3p | 10.2p |
4. | Dividends | | | |
| | Half-year ended 31.12.23 £'000 | Half-year ended 31.12.22 £'000 | Year ended 30.06.23 £'000 |
| Equity dividends paid:
|
| | |
| |
| | |
| Final dividend for the year ended 30 June 2022 | - | 22,921 | 22,921 |
| Interim dividend for the year ended 30 June 2023 | - | - | 9,377 |
| Final dividend for the year ended 30 June 2023 | 23,963 | - | - |
| |
| | |
| | 23,963 | 22,921 | 32,298 |
| |
| | |
| Equity dividends declared/proposed after the end of the period
|
| | |
| Interim dividend | 10,419 | 9,377 | - |
| Final dividend | - | - | 23,963 |
Equity dividends per share, paid and declared/proposed are as follows:
|
5.50p final dividend for the year ended 30 June 2022, paid on 16 December 2022 2.25p interim dividend for the year ended 30 June 2023, paid on 9 June 2023 5.75p final dividend for the year ended 30 June 2023, paid on 15 December 2023
2.50p interim dividend for the year ended 30 June 2024, payable on 14 June 2024, to those shareholders on the register at 17 May 2024
| |
6.
|
Copies of the interim results
|
|
| Copies of the interim results have been sent to shareholders who requested them. Further copies can be obtained from the Company's registered office, Beechfield, Hollinhurst Road, Radcliffe, Manchester, M26 1JN and on the Company's website at www.jameshalstead.com. |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.